Antidote Treatment Nerve Agent Auto-Injector (ATNAA)

Back Print
Agency: DEPT OF DEFENSE
State: Pennsylvania
Level of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Opps ID: NBD00159031714883103
Posted Date: Apr 12, 2024
Due Date: Apr 4, 2024
Solicitation No: SPE2DP-23-R-0002
Source: Members Only
Follow
Antidote Treatment Nerve Agent Auto-Injector (ATNAA)
Active
Contract Opportunity
Notice ID
SPE2DP-23-R-0002
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Major Command
TROOP SUPPORT MEDICAL
Office
DLA TROOP SUPPORT
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Presolicitation (Updated)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Updated Published Date: Apr 12, 2024 07:41 am EDT
  • Original Published Date: Mar 20, 2024 07:52 am EDT
  • Updated Response Date: Apr 04, 2024 11:59 pm EDT
  • Original Response Date: Apr 04, 2024 11:59 pm EDT
  • Inactive Policy: 15 days after response date
  • Updated Inactive Date: Apr 19, 2024
  • Original Inactive Date: Apr 19, 2024
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325414 - Biological Product (except Diagnostic) Manufacturing
  • Place of Performance:
    Philadelphia , PA 19111
    USA
Description

Solicitation: SPE2DP-23-R-0002



Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxime Chloride Injection, 300 mg per mL, 2 mL, and Atropine Injection, 2.99 mg per mL, 0.7 mL



NSN: 6505-01-362-7427



Description:



The Defense Logistics Agency Troop Support has a requirement for the supply of Antidote Treatment Nerve Agent Auto-Injector (ATNAA). ATNAA shall be made in accordance with MPID Number 6 dated May 2, 2019.



The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1).



The Government does not intend to use Part 12 for this acquisition – per FAR 10.002(d)(2).



The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a base year and four (4) one-year options. The quantities for the base year and each option year are a minimum of 225,000 each and a maximum of 1,000,000 each.



Inspection/Acceptance at Destination



FOB Destination



Delivery Destination: Susquehanna, PA



Production Lead Time is 164 days after issuance date of the delivery order (DD1155).



All responsible sources may submit a proposal and shall be considered by the Agency.



The successful contractor shall have FDA approval to sell ATNAA before award decision.





****************************************************************************



IMPORTANT NOTICES



Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.



******************************************************************************


Attachments/Links
Contact Information
Contracting Office Address
  • MEDICAL SUPPLY CHAIN PHARM FSA 700 ROBBINS AVENUE
  • PHILADELPHIA , PA 19111
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Jun 6, 2023[Sources Sought (Original)] Antidote Treatment Nerve Agent Auto-Injector (ATNAA)
Mar 20, 2024[Presolicitation (Original)] Antidote Treatment Nerve Agent Auto-Injector (ATNAA)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >